EMRIS Pharma vs ImmuniQ

EMRIS Pharma vs ImmuniQ, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EMRIS Pharma is on 45/100 and ImmuniQ on 54/100.

EMRIS Pharma logo
EMRIS PharmaDeveloping topical treatments to prevent and treat skin toxicities from cancer therapies.
Try EMRIS Pharma
ImmuniQDevelops a novel method to predict patient response to immune checkpoint inhibitors in oncology.
Try ImmuniQ

Where each one leads

EMRIS Pharma

  • agent readiness: 30/100 against 22/100

ImmuniQ

  • our overall score: 54/100 against 45/100

At a glance

MeasureEMRIS PharmaImmuniQ
What it isDeveloping topical treatments to prevent and treat skin toxicities from cancer therapies.Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.
CategoryLife Sciences, Oncology, Biotech, MedTechLife Sciences, Oncology, Patient Care, Biotech
Sells toBusiness modelB2BB2B
OfferingSoftwareServices
Founded20212021
HeadquartersTel Aviv, IsraelTel Aviv, Israel
StatusActiveInactive

Size, funding and growth

MeasureEMRIS PharmaImmuniQ
Employees7Not published
LinkedIn followers2,441Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEMRIS PharmaImmuniQ
StartupHub scoreOur 0-100 rating45/10054/100
Traction9/10011/100
Team60/100Not published
Search visibility34/100Not published
Quality58/100Not published
Agent readinessHow well an AI agent can read and act on the siteF (30/100)F (22/100)
Domain ratingLink authority, 0-10010/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEMRIS PharmaImmuniQ
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksJqueryNot detected

EMRIS Pharma vs ImmuniQ: common questions

Which is better, EMRIS Pharma or ImmuniQ?

On our 0-100 score ImmuniQ rates higher (54/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.

How do EMRIS Pharma and ImmuniQ compare on the numbers?

EMRIS Pharma leads on agent readiness (30/100 against 22/100). ImmuniQ leads on our overall score (54/100 against 45/100).

Read the full EMRIS Pharma review and pricing or the ImmuniQ review and pricing. You can also browse other EMRIS Pharma alternatives we track.